Palatin Technologies Corporate Presentation 2024

Palatin Technologies is a biopharmaceutical company leveraging its melanocortin system drug development platform to develop therapeutics for inflammatory and autoimmune diseases, obesity, and sexual dysfunctions. The company brings demonstrated expertise in moving programs from discovery to FDA approval, and was the first company to gain FDA approval for a melanocortin agent (Vyleesi®).